Stanley-Laman »

Vertex Pharmaceuticals Incorporated shares owned by Stanley-Laman

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Stanley-Laman from 13F filings

Historical chart of Stanley-Laman investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Stanley-Laman consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Stanley-Laman

Quarter filed Position value Share count Share price at filing
2025-12-31 $220k 485 453.36
2025-06-30 $297k 668 445.20
2025-03-31 $486k 1.0k 484.82
2024-09-30 $203k 436 465.08
2022-03-31 $345k 1.3k 260.77
2020-12-31 $512k 2.2k 236.16
2020-09-30 $328k 1.2k 272.43
2018-12-31 $248k 1.5k 165.55

More positions owned by Stanley-Laman

Alphabet Inc Class Class A Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Raytheon Technologies Corp (RTX)
Asml Hldg N V F Sponsored Adr 1 Adr Reps 1 Ord N Y Registry Shs (ASML)
NVIDIA Corporation (NVDA)
Cameco Corporation (CCJ)
Broadcom (AVGO)
Lam Resh Corp Com New (LRCX)
Apple (AAPL)
TETRA Technologies (TTI)
Intuitive Surgical Com New (ISRG)
Taiwan Semiconductor M F Sponsored Adr 1 Adr Reps 5 Ord Sponsored Adr (TSM)
Kla Corp Com New (KLAC)
Vanguard S&p 500 Etf S&p 500 Etf Shs (VOO)

View all positions for Stanley-Laman

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated